Literature DB >> 1864099

Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases.

A Frustaci1, M Caldarulo, A Buffon, F Bellocci, R Fenici, D Melina.   

Abstract

Fourteen patients (ten men and four women; mean age, 37 years) with lone atrial fibrillation (AF) (1 to 18 months' duration) were evaluated by thyroid function tests, two-dimensional echocardiography, hemodynamics, coronary angiography, and left ventricular endomyocardial biopsy, because of unresponsiveness to the usual antiarrhythmic therapy. The results of the T3, T4, TSH, and TRH tests were normal in all patients; cardiac valves and ventricular and atrial sizes (left atrium less than 40 mm) were within the normal limits; also normal were LVEDP (less than or equal to 10 mm Hg) and EF (greater than 0.50). Histologic findings were abnormal in all cases, with three patients showing cardiomyopathic changes, three other patients showing active myocarditis (lymphocytic in two and eosinophilic in one), and eight patients with nonspecific necrosis or fibrosis or both. Steroids (prednisone; 50 mg/m2 of body surface area daily) used in addition to antiarrhythmic therapy in patients with eosinophilic and lymphocytic active myocarditis were able to cause reversion to sinus rhythm, while the other patients continued to have AF. This study documents that occult myocardial diseases (myocarditis, cardiomyopathy, and nonspecific necrosis or fibrosis) can underlie "primary" AF. The addition of steroids to antiarrhythmic therapy in patients with refractory AF and histologic evidence of active myocarditis seems to be useful in controlling the arrhythmia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864099     DOI: 10.1378/chest.100.2.303

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  32 in total

1.  Myocarditis associated with reovirus infection.

Authors:  F Terheggen; E Benedikz; P H J Frissen; K Brinkman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-01       Impact factor: 3.267

Review 2.  Atrial fibrillation in congestive heart failure.

Authors:  Steven A Lubitz; Emelia J Benjamin; Patrick T Ellinor
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

3.  Prevalence of virulent Helicobacter pylori strains in patients affected by idiopathic dysrhythmias.

Authors:  Francesco Franceschi; Donatella Brisinda; Francesco Buccelletti; Maria Pia Ruggieri; Antonio Gasbarrini; Annarita Sorbo; Davide Marsiliani; Angela Venuti; Peter Fenici; Giovanni Gasbarrini; Nicolò Gentiloni Silveri; Riccardo Fenici
Journal:  Intern Emerg Med       Date:  2011-05-12       Impact factor: 3.397

Review 4.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

Review 5.  Lone AF - Etiologic Factors and Genetic Insights into Pathophysiolgy.

Authors:  Babar Parvez; Dawood Darbar
Journal:  J Atr Fibrillation       Date:  2010-06-01

6.  Myocardial Biopsy In "Idiopathic» Atrial Fibrillation And Other Arrhythmias: Nosological Diagnosis, Clinical And Morphological Parallels, And Treatment.

Authors:  O V Blagova; A V Nedostup; E A Kogan; V A Sulimov; S A Abugov; A G Kupriyanova; V A Zaydenov; A E Donnikov; E V Zaklyazminskaya; E A Okisheva
Journal:  J Atr Fibrillation       Date:  2016-06-30

7.  Elevated levels of RDW is associated with non-valvular atrial fibrillation.

Authors:  Barış Güngör; Kazım Serhan Özcan; İzzet Erdinler; Ahmet Ekmekçi; Ahmet Taha Alper; Damirbek Osmonov; Nazmi Çalık; Sukru Akyuz; Ercan Toprak; Hale Yılmaz; Aydın Yıldırım; Osman Bolca
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

8.  Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts.

Authors:  Ashish Parikh; Divyang Patel; Charles F McTiernan; Wenyu Xiang; Jamie Haney; Lei Yang; Bo Lin; Aaron D Kaplan; Glenna C L Bett; Randall L Rasmusson; Sanjeev G Shroff; David Schwartzman; Guy Salama
Journal:  Circ Res       Date:  2013-06-07       Impact factor: 17.367

9.  Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.

Authors:  Tomas G Neilan; Francois-Pierre Mongeon; Ravi V Shah; Otavio Coelho-Filho; Siddique A Abbasi; John A Dodson; Ciaran J McMullan; Bobak Heydari; Gregory F Michaud; Roy M John; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2013-11-27

10.  Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.

Authors:  Sander Verheule; Toshiaki Sato; Thomas Everett; Steven K Engle; Dan Otten; Michael Rubart-von der Lohe; Hisako O Nakajima; Hidehiro Nakajima; Loren J Field; Jeffrey E Olgin
Journal:  Circ Res       Date:  2004-04-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.